Paget-Schroetter disease secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
(One intermediate revision by one other user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Paget-Schroetter disease}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{Anahita}} | ||
==Overview== | ==Overview== | ||
There are no established measures for the [[Prevention (medical)|secondary prevention]] of [[Paget-Schroetter disease]]. | There are no established measures for the [[Prevention (medical)|secondary prevention]] of [[Paget-Schroetter disease]]. | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
There are no established measures for the [[Prevention (medical)|secondary prevention]] of [[Paget-Schroetter disease]]. | *There are no established measures for the [[Prevention (medical)|secondary prevention]] of [[Paget-Schroetter disease]]. | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Angiology]] | [[Category:Angiology]] |
Latest revision as of 20:23, 23 June 2020
Paget-Schroetter disease Microchapters |
Differentiating Paget-Schroetter disease from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Paget-Schroetter disease secondary prevention On the Web |
American Roentgen Ray Society Images of Paget-Schroetter disease secondary prevention |
Risk calculators and risk factors for Paget-Schroetter disease secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anahita Deylamsalehi, M.D.[2]
Overview
There are no established measures for the secondary prevention of Paget-Schroetter disease.
Secondary Prevention
- There are no established measures for the secondary prevention of Paget-Schroetter disease.